Valérie Seffer

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

Odile Launay, Christine Sadorge, Nathalie Jolly et al. · Vaccine · 2009 · 44 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) Signaling

Sandra Bos, Béatrice Poirier-Beaudouin, Valérie Seffer et al. · Frontiers in Immunology · 2020 · 19 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles

Catherine Goujon, Marie‐Lise Gougeon, Laura Tondeur et al. · Vaccine · 2017 · 18 citations

Veterinary Medicine, Immunology, Pediatrics +14

HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)

Marie‐Lise Gougeon, Béatrice Poirier-Beaudouin, J. Durant et al. · Heliyon · 2017 · 17 citations · Full text

Life Sciences, Infectious Diseases, Neurology +13

Immune profiling in subclinical secondary dengue-infected cases reveals adaptive immune signatures correlated to protection from severe dengue

Giorgio Gonnella, Valentina Libri, Emanuele Gioacchino et al. · Cell Host & Microbe · 2025 · 14 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17